Osteoarthritis
Conditions
Brief summary
The USAGE study aims at assessing on a long-term period (two years in average) the outcome in clinical or economical term of patients with knee osteoarthritis (OA) treated or not with Synvisc®, in the 1139.4 clinical trial.
Interventions
None listed
Sponsors
Boehringer Ingelheim
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients have already been followed up on a nine-month period in a pragmatic medica-economical clinical trial (BI Trial No.: 1139.4)
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Lequesne index | up to 2 years | assessment of algo-functional severity of pathology |
| Change in Womac index | up to 2 years | assessment of symptom severity |
Secondary
| Measure | Time frame |
|---|---|
| Medical costs related to knee osteoarthritis | up to 2 years |
Outcome results
None listed